Corin

Focus: Corin is a UK-based orthopedic medical device company specializing in hip and knee arthroplasty systems. The company is publicly listed and operates in the musculoskeletal space with a portfolio of established implant platforms.

Musculoskeletal

Profile data last refreshed 17h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Corin

AI assessmentNot Hiring

No open roles listed right now. Follow Corin to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

22 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Trinity™ Acetabular Cup

Total Hip Arthroplasty

Peak

Flagship hip acetabular component with established clinical outcomes across multiple surgical approaches and stem combinations.

TriFit™/TriFit-CF™/TriFit-TS™ Femoral Stem

Total Hip Arthroplasty

Help build intelligence for Corin

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Established public company with proven orthopedic implant portfolio including Trinity, TriFit, Unity, and Cormet systems across hip and knee replacement markets
Portfolio spans multiple clinical trial programs (20 ongoing studies) demonstrating active clinical engagement and long-term outcome research
Medical device focus offers hands-on clinical impact in high-volume orthopedic procedures affecting millions of patients annually

Watch Out For

Zero active job openings indicates potential hiring freeze or organizational stability concerns, limiting near-term career mobility
Limited public financial data (revenue, R&D spend, cash position) restricts ability to assess company health and investment trajectory
Orthopedic implant market is highly competitive with established players (Stryker, Zimmer Biomet, Johnson & Johnson) creating differentiation challenges

Generated by Claude from Corin's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Key femoral stem offering with multiple design variants (collared, cementless) supporting diverse surgical techniques.

Unity Knee™ TKR System

Total Knee Arthroplasty/Osteoarthritis

Peak

Total knee replacement system available in standard and measured-resection configurations for diverse patient anatomy.

Cormet Hip Resurfacing System

Osteoarthritis/Hip Resurfacing

Peak

Alternative to traditional arthroplasty for younger patients with hip osteoarthritis requiring metal-on-metal articulation.

MiniHip Stem

Total Hip Arthroplasty

Growth

Minimal invasive femoral stem option addressing surgeon interest in smaller implant footprints and reduced soft tissue trauma.

Pipeline & Clinical Trials

Primary Total Hip Replacement with Metafix™ femoral stem and Trinity™ acetabular cup or TriFit-CF™/TriFit-TS™ femoral stem and Trinity™ acetabular cup implanted by a single surgeon.

Primary Total Hip Arthroplasty

N/A

Clinical Trials (1)

NCT04319952OPS™ With Direct Anterior Approach (DAA)

N/A

MiniHip Stem

Total Hip Arthroplasty

N/A

Clinical Trials (1)

NCT05186168Corin MiniHip and Trinity Cup Clinical Surveillance Study

N/A

patient with knee arthroplasty